Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

U.S. could recommend COVID-19 boosters at five months, according to Biden 

By Brian Buntz | August 27, 2021

President Joe Biden

President Joe Biden [Image courtesy of the White House]

Facing the second-largest COVID-19 wave to date, U.S. regulators are mulling providing boosters three months earlier than initially anticipated.

People who are fully vaccinated would be eligible for a booster dose five months after receiving the second dose, Biden said, noting that the plan was still tentative.

On Aug. 18, U.S. Surgeon General Vivek Murthy said fully vaccinated individuals would be eligible for boosters eight months after administering the second dose of Pfizer or Moderna vaccines.

On Aug. 29, Chief Medical Advisor to the President Dr. Anthony Fauci, noted that administration would stick with the eight-month window, but noted that government officials would be flexible as more data arrive. In an ABC interview, Fauci said the government could adjust the timetable. “If the data tells us differently, we’ll make adjustments accordingly,” he said.

Earlier this week, WSJ reported that the U.S. was likely to approve boosters at six months.

Regarding the latest potential revision, Biden said U.S. officials were considering advice that “we should start earlier.”

FDA is likely to authorize boosters in September.

Distribution could start on Sept. 20, according to media reports.

The Biden administration has dismissed WHO’s request to withhold booster shots to prioritize vaccinating low-income nations, arguing that the U.S. can simultaneously prioritize distributing vaccines domestically and internationally.

To date, approximately 0.3% of vaccine doses have been administered in low-income nations, according to The New York Times.

Israel has already begun administering boosters to high-risk individuals. Scientists there credit the policy with helping beat back the spread of the Delta variant.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

institut pasteur dakar IPD African Union vaccine investment
African Union vaccine initiative receives $45M
Sen-Jam Pharma, KVK-Tech partnering for manufacturing and formulation for anti-inflammatory injectables
This image shows the Moderna logo.
Moderna resizes its manufacturing footprint for a post-pandemic era
This is the logo of Pfizer.
Pfizer to close Durham and Morrisville, North Carolina facilities amid major restructuring effort
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE